Stocks Funds Screener Sectors Watchlists

Latest ARMISTICE CAPITAL, LLC Stock Portfolio

$5.62Billion– No. of Holdings #251

ARMISTICE CAPITAL, LLC Performance:

2026 Q1: -7.34%YTD: -7.34%2025: 10.43%

Performance for 2026 Q1 is -7.34%, and YTD is -7.34%, and 2025 is 10.43%.

About ARMISTICE CAPITAL, LLC and 13F Hedge Fund Stock Holdings

ARMISTICE CAPITAL, LLC is a hedge fund based in New York, NY. On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, ARMISTICE CAPITAL, LLC reported an equity portfolio of $5.6 Billions as of 31 Mar, 2026.

The top stock holdings of ARMISTICE CAPITAL, LLC are TVTX, PTCT, MDGL. The fund has invested 2.6% of it's portfolio in TRAVERE THERAPEUTICS INC and 2.5% of portfolio in PTC THERAPEUTICS INC.

The fund managers got completely rid off ARGENX SE (ARGX), STARBUCKS CORP (SBUX) and MEDTRONIC PLC (MDT) stocks. They significantly reduced their stock positions in KENVUE INC, ZETA GLOBAL HOLDINGS CORP (ZETA) and PDS BIOTECHNOLOGY CORP (PDSB). ARMISTICE CAPITAL, LLC opened new stock positions in UNITEDHEALTH GROUP INC (UNH), META PLATFORMS INC (META) and CENTRAL GARDEN & PET CO (CENT). The fund showed a lot of confidence in some stocks as they added substantially to CORNING INC (GLW), BLOOM ENERGY CORP (BE) and MEDLINE INC.

ARMISTICE CAPITAL, LLC Equity Portfolio Value

Last Reported on: 15 May, 2026

ARMISTICE CAPITAL, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that ARMISTICE CAPITAL, LLC made a return of -7.34% in the last quarter. In trailing 12 months, it's portfolio return was 12.85%.

Performance
S&P 500

New Buys

Ticker	$ Bought
unitedhealth group inc	40,047,300
meta platforms inc	18,648,000
central garden & pet co	15,496,800
capri holdings limited	11,594,000
xeris biopharma holdings inc	11,077,100
esperion therapeutics inc ne	10,768,500
iqvia hldgs inc	10,383,200
sangamo therapeutics inc	9,974,780

New stocks bought by ARMISTICE CAPITAL, LLC

Additions

Ticker	% Inc.
corning inc	1,127
bloom energy corp	987
medline inc	873
comfort sys usa inc	652
sandisk corp	486
harmony biosciences hldgs in	224
roblox corp	154
toast inc	153

Additions to existing portfolio by ARMISTICE CAPITAL, LLC

Reductions

Ticker	% Reduced
kenvue inc	-99.26
zeta global holdings corp	-97.43
pds biotechnology corp	-93.88
e l f beauty inc	-91.58
ge healthcare technologies i	-85.06
agree rlty corp	-78.41
gsk plc	-76.4
worksport ltd	-74.1

ARMISTICE CAPITAL, LLC reduced stake in above stock

Sold off

Ticker	$ Sold
akari therapeutics plc	-787,226
adial pharmaceuticals inc	-561,977
gold royalty corp	-4,356,000
medicus pharma ltd	-2,770,770
mangoceuticals inc	-1,136,640
nanoviricides inc	-1,545,840
curis inc	-872,186
mainz biomed n v	-868,295

ARMISTICE CAPITAL, LLC got rid off the above stocks

Sector Distribution

ARMISTICE CAPITAL, LLC has about 62.1% of it's holdings in Healthcare sector.

Healthcare
Technology
Others
Consumer Cyclical
Consumer Defensive
Communication Services
Industrials

Sector	%
Healthcare	62.1
Technology	12.7
Others	12.1
Consumer Cyclical	6.8
Consumer Defensive	2.8
Communication Services	1.9
Industrials	1.4

Market Cap. Distribution

ARMISTICE CAPITAL, LLC has about 33.2% of it's portfolio invested in the large-cap and mega-cap stocks.

MID-CAP
LARGE-CAP
SMALL-CAP
UNALLOCATED
MEGA-CAP
MICRO-CAP

Category	%
MID-CAP	31
LARGE-CAP	26.2
SMALL-CAP	20.3
UNALLOCATED	12.2
MEGA-CAP	7
MICRO-CAP	2.7

Stocks belong to which Index?

About 65.7% of the stocks held by ARMISTICE CAPITAL, LLC either belong to S&P 500 or RUSSELL 2000 index.

RUSSELL 2000
Others
S&P 500

Index	%
RUSSELL 2000	45.1
Others	34.2
S&P 500	20.6

Top 5 Winners (%)		%
MGNX	macrogenics inc	77.5 %
NKTR	nektar therapeutics	69.1 %
REED	reeds inc	68.7 %
DOW	dow hldgs inc	65.6 %
CIEN	ciena corp	58.8 %

Top 5 Winners ($)		$
AGIO	agios pharmaceuticals inc	19.0 M
NKTR	nektar therapeutics	17.4 M
MGNX	macrogenics inc	7.9 M
AVNS	avanos med inc	7.2 M
	alto neuroscience inc	5.7 M

Top 5 Losers (%)		%
NXGL	nexgel inc	-74.5 %
MTP	biodexa pharmaceuticals plc	-71.9 %
IVDA	iveda solutions inc	-66.3 %
BEAT	heartbeam inc	-62.5 %
ARAY	accuray inc del	-50.3 %

Top 5 Losers ($)		$
TVTX	travere therapeutics inc	-36.8 M
PTCT	ptc therapeutics inc	-19.1 M
RIGL	rigel pharmaceuticals inc	-16.7 M
MDGL	madrigal pharmaceuticals inc	-15.6 M
HUBS	hubspot inc	-15.5 M

ARMISTICE CAPITAL, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL, LLC has 251 stocks in it's portfolio. About 17.5% of the portfolio is in top 10 stocks. TVTX proved to be the most loss making stock for the portfolio. AGIO was the most profitable stock for ARMISTICE CAPITAL, LLC last quarter.

Last Reported on: 15 May, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
AAL	american airlines group inc	0.00	10,335	110,998	reduced	-68.21

AAOI	applied optoelectronics inc	0.00	3,080	260,537	new

ABC	cencora inc	0.00	0.00	0.00	sold off	-100

ABCB	ameris bancorp	0.00	0.00	0.00	sold off	-100

ABNB	airbnb inc	0.03	15,190	1,918,190	reduced	-26.59

ADBE	adobe inc	0.00	0.00	0.00	sold off	-100

ADC	agree rlty corp	0.00	3,025	228,025	reduced	-78.41

ADI	analog devices inc	0.01	1,033	328,639	new

ADIL	adial pharmaceuticals inc	0.00	0.00	0.00	sold off	-100

ADM	archer daniels midland co	0.00	0.00	0.00	sold off	-100

AEO	american eagle outfitters in	0.00	0.00	0.00	sold off	-100

AFL	aflac inc	0.00	0.00	0.00	sold off	-100

AGIO	agios pharmaceuticals inc	1.63	2,716,000	91,882,300	reduced	-10.54

AGLE	spyre therapeutics inc	0.11	120,931	6,099,760	reduced	-38.43

AGNC	agnc invt corp	0.01	35,740	358,472	new

AGO	assured guaranty ltd	0.00	0.00	0.00	sold off	-100

AIR	aar corp	0.00	0.00	0.00	sold off	-100

AKTX	akari therapeutics plc	0.00	38,922	200,448	new

AKTX	akari therapeutics plc	0.00	0.00	0.00	sold off	-100

ALC	alcon ag	0.00	0.00	0.00	sold off	-100